Agendia, a developer of molecular diagnostic tools, has appointed David Macdonald as chief executive officer (CEO).
Since April 2010, Macdonald served as the Agendia’s COO and has also developed clinical diagnostics and laboratory services for companies including Behring Diagnostics, Nichols Institute, Nova Biomedical,and Quest Diagnostics.
In addition, the company has also appointed Colin Goddard as its supervisory board member.
Previously, Goddard served as executive chairman and CEO of Coferon and also served as a director of biotechnology companies including PanOptica and Human Genome Sciences.
Goddard is also involved as an advisor to several venture capital firms and other industry groups.